Food Additive Emulsifier Intake Linked to Risk for CVD
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Sept. 8, 2023 -- Intake of food additive emulsifiers is associated with an increased risk for cardiovascular disease (CVD), according to a study published online Sept. 6 in The BMJ.
Laury Sellem, Ph.D., from Université Sorbonne Paris Nord, and colleagues examined the associations between exposure to food additive emulsifiers (i.e., total modified starches, lecithins, xanthan gum, pectins, monoglycerides and diglycerides of fatty acids, carrageenan, and guar gum) and the risk for CVD in a prospective cohort study involving 95,442 adults without prevalent CVD. Participants included a cohort from the French NutriNet-Santé study launched in 2009.
The researchers found that 1,995 incident CVD, 1,044 coronary heart disease, and 974 cerebrovascular disease events were diagnosed during a median follow-up of 7.4 years. Higher intake of celluloses (E460 and E468) was positively associated with elevated risks for CVD (hazard ratio, 1.05 per one standard deviation) and coronary heart disease (hazard ratio, 1.07). Higher risks for CVD and coronary heart disease were seen in association with higher cellulose E460 intake (hazard ratios, 1.05 and 1.07, respectively) and with higher intake of carboxymethylcellulose (E466; (azard ratios, 1.03 and 1.04, respectively). Higher risks for all outcomes were seen in association with higher intakes of monoglycerides and diglycerides of fatty acids (E471 and E472). An increased risk for coronary heart disease was seen in association with high intake of trisodium phosphate (E339; hazard ratio, 1.06).
"Results from this large prospective cohort suggest that additive emulsifiers may be associated with an increased risk of CVD," the authors write. "Despite the moderate magnitude of the associations, these findings may have important public health implications given that these food additives are used ubiquitously in thousands of widely consumed ultra-processed food products."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
Statins Reduce CVD Risk in Adults Aged 75 to 85 and 85 Years and Older
TUESDAY, May 28, 2024 -- For patients aged 75 years and older, statin therapy is associated with a risk reduction in cardiovascular diseases (CVDs), according to a study published...
Fish Oil Beneficial for Reducing Risk for Cardiovascular Disease Progression
WEDNESDAY, May 22, 2024 -- The role of regular use of fish oil supplements varies for people with and without cardiovascular disease, according to a study published online May 21...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.